PPT-Ethical Considerations for Medication Assisted Treatment and Recovery:

Fighting the Stigma Jeffrey Quamme Executive Director Connecticut Certification Board 2018 UVU Conference Orem Utah Our Goals For Today Understand the history of MAT for Opioid Use Disorders. Mark Stringer, Director. Missouri Divisions of Alcohol and Drug Abuse & Comprehensive Psychiatric Services. NASADAD Annual Meeting. Indianapolis, IN. June 8, 2011. Medication Assisted Treatment Timeline. Law and Ethics in Counseling Conference 2016. New Orleans April 7, 2016. J. Scott Hinkle, Ph.D., NCC. Introduction. This presentation will cover . some ethical . considerations with the administration and maintenance of psychopharmacological . Presented by:. NJATOD Officers. Barbara . Schlichting. , NJATOD Secretary, Somerset Treatment Services . Christie . Hanvey. , NJATOD Vice President, Spectrum Healthcare Center. . Maiysha. Ware, NJATOD President, The . Wilma Townsend. DPT, Team Leader. November 20, 2014. Objectives. (. 1) increase the field’s knowledge of medication units and their usefulness and barriers to implementation; . (. 2) demonstrate how medication units increase treatment capacity and access to care, . Wilma Townsend. DPT, Team Leader. November 20, 2014. Objectives. (. 1) increase the field’s knowledge of medication units and their usefulness and barriers to implementation; . (. 2) demonstrate how medication units increase treatment capacity and access to care, . Mark Stringer, Director. Missouri Divisions of Alcohol and Drug Abuse & Comprehensive Psychiatric Services. NASADAD Annual Meeting. Indianapolis, IN. June 8, 2011. Medication Assisted Treatment Timeline. for Addiction: . Bias and Burnout. Kevin Carl, MD. What is Medication Assisted Treatment (MAT)?. The use of . medications. in combination with counseling and behavioral therapies for the . treatment. Nick Szubiak, MSW, LCSW. Director, Clinical Excellence in Addictions. National Council for Behavioral Health. Objectives. Understand why and how Medication Assisted Treatment works and why we don't use it by challenging the way we view, judge and think about addiction.. MAT BASICS Peter Mason MD Medical Director Region 1 IDN Opioid Use Disorder (OUD) Opioid Use Disorder (OUD): A medical condition characterized by a problematic pattern of opioid use that causes clinically significant impairment or distress. The Fundamentals of Medication Assisted Treatment Nick Szubiak, MSW, LCSW Director, Clinical Excellence in Addictions National Council for Behavioral Health Objectives Understand why and how Medication Assisted Treatment works and why we don't use it by challenging the way we view, judge and think about addiction. Some Best practices with medication assisted treatment Michele Flowers McCarthy, LPCC-S Director of Program Development Center for Behavioral Health Special thanks to Michele McCarthy Director of Program Development Nick Szubiak, MSW, LCSW. Director, Clinical Excellence in Addictions. National Council for Behavioral Health. Objectives. Understand why and how Medication Assisted Treatment works and why we don't use it by challenging the way we view, judge and think about addiction.. Breaking the Stigma. Christie Simons, MAMFT, LPCA, LCAS-A. Director of Counselor Services, Belmont Abbey College . McLeod Addictive Disease Center . Medication-Assisted Treatment. Introduction . Common Myths?. Michael Dulitz, MPH, NRP. Opioid Response Project Coordinator. Foundation. Addiction is a . chronic relapsing brain disease . characterized by compulsive use of a substance despite negative consequences.